+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Thyroid Cancer Diagnostics - Global Market Outlook (2019-2027)

  • ID: 5157536
  • Report
  • August 2020
  • Region: Global
  • 208 pages
  • Stratistics Market Research Consulting Pvt Ltd

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • F.Hoffmann-La Roche Ltd.
  • General Electric
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • Siemens Healthcare GmbH
  • MORE
According to the report, the Global Thyroid Cancer Diagnostics Market accounted for $2.4 billion in 2019 and is expected to reach $4.31 billion by 2027, growing at a CAGR of 7.6% during the forecast period.

Some of the key factors propelling the market growth include rising prevalence of thyroid cancer, increase in the number of initiatives by governments, rise in funding for research, and increasing emphasis on early diagnosis and treatment. However,
Lack of knowledge about exact causative factors and late diagnosis of the disease are some key factors restraining the growth of the market. Moreover, rising healthcare expenditure and increasing technological advancements are creating growth opportunities for the market.

Thyroid cancer is a type of cancer that occurs when abnormal cell begin to grow in thyroid gland, responsible for the excretion of thyroid hormones. It is asymptotic in early stage and progresses with formation of lump in thyroid gland. If diagnosed in early stage it can be treated easily.

By technique, the imaging segment is anticipated to grow at the significant rate during the forecast period.

Imaging tests remain the mainstay in thyroid cancer for purposes of disease diagnostics and cancer staging. Neck ultrasound or CT/MRI scans are the most recommended diagnostic tools for disease identification. Other imaging tests such as chest X-ray, bone scans, PET scan, and radioiodine scans are used for staging and identifying metastasis. Technological advancements and relatively high cost are key revenue generators for this segment in the thyroid cancer diagnostics market.

On the basis of geography, the market in Asia-Pacific is expected to grow at the significant rate during the forecast period, owing to factors such as the increasing prevalence of thyroid cancer, a rise in consumer awareness improvement in healthcare infrastructure, and increase in disposable income. The market for thyroid cancer diagnostics in emerging countries such as China, India, and South Korea is expected to witness rapid growth during the forecast period.

Some of the key players in Thyroid Cancer Diagnostics Market include bio-Rad Laboratories, Inc., General Electric, Koninklijke Philips N.V., Abbott, F.Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Illumina, Inc., Thermo Fisher Scientific, Inc., Siemens Healthcare GmbH, and Toshiba Corporation.

Techniques Covered:
  • Imaging
  • Blood Tests
  • Biopsy
  • Ultrasound
  • Radioiodine Scan
  • Magnetic Resonance Imaging (MRI) Scan
  • Positron Emission Tomography (PET) Scan
  • Computed Tomography (CT) Scan
  • Molecular Testing
Types Covered:
  • Follicular Carcinoma
  • Papillary Carcinoma
End-users Covered:
  • Research & Academic Institutes
  • Hospitals & Ambulatory Surgery Centers
  • Cancer Diagnostic Centers
  • Independent Diagnostic Labs
  • Diagnostic Imaging Centers
Regions Covered:

North America
  • US
  • Canada
  • Mexico
Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of Asia-Pacific
South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa
What the report offers:
  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and Recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
Free Customization Offerings

Purchasers of this report will be entitled to receive one of the following free customization options:

1. Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
2. Regional Segmentation
  • Market estimations, forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
3. Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • F.Hoffmann-La Roche Ltd.
  • General Electric
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • Siemens Healthcare GmbH
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End-user Analysis
3.7 Emerging Markets
3.8 Impact of COVID-19

4 Porters Five Forces Analysis
4.1 Bargaining Power of Suppliers
4.2 Bargaining Power of Buyers
4.3 Threat of Substitutes
4.4 Threat of New Entrants
4.5 Competitive Rivalry

5 Global Thyroid Cancer Diagnostics Market, By Technique
5.1 Introduction
5.2 Imaging
5.3 Blood Tests
5.4 Biopsy
5.5 Ultrasound
5.6 Radioiodine Scan
5.7 Magnetic Resonance Imaging (MRI) Scan
5.8 Positron Emission Tomography (PET) Scan
5.9 Computed Tomography (CT) Scan
5.10 Molecular Testing

6 Global Thyroid Cancer Diagnostics Market, By Type
6.1 Introduction
6.2 Follicular Carcinoma
6.3 Papillary Carcinoma

7 Global Thyroid Cancer Diagnostics Market, By End-user
7.1 Introduction
7.2 Research & Academic Institutes
7.3 Hospitals & Ambulatory Surgery Centers
7.4 Cancer Diagnostic Centers
7.5 Independent Diagnostic Labs
7.6 Diagnostic Imaging Centers

8 Global Thyroid Cancer Diagnostics Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia-Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launches
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Bio-Rad Laboratories, Inc.
10.2 General Electric
10.3 Koninklijke Philips N.V.
10.4 Abbott
10.5 F.Hoffmann-La Roche Ltd.
10.6 Agilent Technologies, Inc.
10.7 Illumina, Inc.
10.8 Thermo Fisher Scientific, Inc.
10.9 Siemens Healthcare GmbH
10.10 Toshiba Corporation

List of Tables
Table 1 Global Thyroid Cancer Diagnostics Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Thyroid Cancer Diagnostics Market Outlook, By Technique (2018-2027) ($MN)
Table 3 Global Thyroid Cancer Diagnostics Market Outlook, By Imaging (2018-2027) ($MN)
Table 4 Global Thyroid Cancer Diagnostics Market Outlook, By Blood Tests (2018-2027) ($MN)
Table 5 Global Thyroid Cancer Diagnostics Market Outlook, By Biopsy (2018-2027) ($MN)
Table 6 Global Thyroid Cancer Diagnostics Market Outlook, By Ultrasound (2018-2027) ($MN)
Table 7 Global Thyroid Cancer Diagnostics Market Outlook, By Radioiodine Scan (2018-2027) ($MN)
Table 8 Global Thyroid Cancer Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) Scan (2018-2027) ($MN)
Table 9 Global Thyroid Cancer Diagnostics Market Outlook, By Positron Emission Tomography (PET) Scan (2018-2027) ($MN)
Table 10 Global Thyroid Cancer Diagnostics Market Outlook, By Computed Tomography (CT) Scan (2018-2027) ($MN)
Table 11 Global Thyroid Cancer Diagnostics Market Outlook, By Molecular Testing (2018-2027) ($MN)
Table 12 Global Thyroid Cancer Diagnostics Market Outlook, By Type (2018-2027) ($MN)
Table 13 Global Thyroid Cancer Diagnostics Market Outlook, By Follicular Carcinoma (2018-2027) ($MN)
Table 14 Global Thyroid Cancer Diagnostics Market Outlook, By Papillary Carcinoma (2018-2027) ($MN)
Table 15 Global Thyroid Cancer Diagnostics Market Outlook, By End-user (2018-2027) ($MN)
Table 16 Global Thyroid Cancer Diagnostics Market Outlook, By Research & Academic Institutes (2018-2027) ($MN)
Table 17 Global Thyroid Cancer Diagnostics Market Outlook, By Hospitals & Ambulatory Surgery Centers (2018-2027) ($MN)
Table 18 Global Thyroid Cancer Diagnostics Market Outlook, By Cancer Diagnostic Centers (2018-2027) ($MN)
Table 19 Global Thyroid Cancer Diagnostics Market Outlook, By Independent Diagnostic Labs (2018-2027) ($MN)
Table 20 Global Thyroid Cancer Diagnostics Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)
Table 21 North America Thyroid Cancer Diagnostics Market Outlook, By Country (2018-2027) ($MN)
Table 22 North America Thyroid Cancer Diagnostics Market Outlook, By Technique (2018-2027) ($MN)
Table 23 North America Thyroid Cancer Diagnostics Market Outlook, By Imaging (2018-2027) ($MN)
Table 24 North America Thyroid Cancer Diagnostics Market Outlook, By Blood Tests (2018-2027) ($MN)
Table 25 North America Thyroid Cancer Diagnostics Market Outlook, By Biopsy (2018-2027) ($MN)
Table 26 North America Thyroid Cancer Diagnostics Market Outlook, By Ultrasound (2018-2027) ($MN)
Table 27 North America Thyroid Cancer Diagnostics Market Outlook, By Radioiodine Scan (2018-2027) ($MN)
Table 28 North America Thyroid Cancer Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) Scan (2018-2027) ($MN)
Table 29 North America Thyroid Cancer Diagnostics Market Outlook, By Positron Emission Tomography (PET) Scan (2018-2027) ($MN)
Table 30 North America Thyroid Cancer Diagnostics Market Outlook, By Computed Tomography (CT) Scan (2018-2027) ($MN)
Table 31 North America Thyroid Cancer Diagnostics Market Outlook, By Molecular Testing (2018-2027) ($MN)
Table 32 North America Thyroid Cancer Diagnostics Market Outlook, By Type (2018-2027) ($MN)
Table 33 North America Thyroid Cancer Diagnostics Market Outlook, By Follicular Carcinoma (2018-2027) ($MN)
Table 34 North America Thyroid Cancer Diagnostics Market Outlook, By Papillary Carcinoma (2018-2027) ($MN)
Table 35 North America Thyroid Cancer Diagnostics Market Outlook, By End-user (2018-2027) ($MN)
Table 36 North America Thyroid Cancer Diagnostics Market Outlook, By Research & Academic Institutes (2018-2027) ($MN)
Table 37 North America Thyroid Cancer Diagnostics Market Outlook, By Hospitals & Ambulatory Surgery Centers (2018-2027) ($MN)
Table 38 North America Thyroid Cancer Diagnostics Market Outlook, By Cancer Diagnostic Centers (2018-2027) ($MN)
Table 39 North America Thyroid Cancer Diagnostics Market Outlook, By Independent Diagnostic Labs (2018-2027) ($MN)
Table 40 North America Thyroid Cancer Diagnostics Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)
Table 41 Europe Thyroid Cancer Diagnostics Market Outlook, By Country (2018-2027) ($MN)
Table 42 Europe Thyroid Cancer Diagnostics Market Outlook, By Technique (2018-2027) ($MN)
Table 43 Europe Thyroid Cancer Diagnostics Market Outlook, By Imaging (2018-2027) ($MN)
Table 44 Europe Thyroid Cancer Diagnostics Market Outlook, By Blood Tests (2018-2027) ($MN)
Table 45 Europe Thyroid Cancer Diagnostics Market Outlook, By Biopsy (2018-2027) ($MN)
Table 46 Europe Thyroid Cancer Diagnostics Market Outlook, By Ultrasound (2018-2027) ($MN)
Table 47 Europe Thyroid Cancer Diagnostics Market Outlook, By Radioiodine Scan (2018-2027) ($MN)
Table 48 Europe Thyroid Cancer Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) Scan (2018-2027) ($MN)
Table 49 Europe Thyroid Cancer Diagnostics Market Outlook, By Positron Emission Tomography (PET) Scan (2018-2027) ($MN)
Table 50 Europe Thyroid Cancer Diagnostics Market Outlook, By Computed Tomography (CT) Scan (2018-2027) ($MN)
Table 51 Europe Thyroid Cancer Diagnostics Market Outlook, By Molecular Testing (2018-2027) ($MN)
Table 52 Europe Thyroid Cancer Diagnostics Market Outlook, By Type (2018-2027) ($MN)
Table 53 Europe Thyroid Cancer Diagnostics Market Outlook, By Follicular Carcinoma (2018-2027) ($MN)
Table 54 Europe Thyroid Cancer Diagnostics Market Outlook, By Papillary Carcinoma (2018-2027) ($MN)
Table 55 Europe Thyroid Cancer Diagnostics Market Outlook, By End-user (2018-2027) ($MN)
Table 56 Europe Thyroid Cancer Diagnostics Market Outlook, By Research & Academic Institutes (2018-2027) ($MN)
Table 57 Europe Thyroid Cancer Diagnostics Market Outlook, By Hospitals & Ambulatory Surgery Centers (2018-2027) ($MN)
Table 58 Europe Thyroid Cancer Diagnostics Market Outlook, By Cancer Diagnostic Centers (2018-2027) ($MN)
Table 59 Europe Thyroid Cancer Diagnostics Market Outlook, By Independent Diagnostic Labs (2018-2027) ($MN)
Table 60 Europe Thyroid Cancer Diagnostics Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)
Table 61 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Country (2018-2027) ($MN)
Table 62 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Technique (2018-2027) ($MN)
Table 63 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Imaging (2018-2027) ($MN)
Table 64 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Blood Tests (2018-2027) ($MN)
Table 65 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Biopsy (2018-2027) ($MN)
Table 66 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Ultrasound (2018-2027) ($MN)
Table 67 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Radioiodine Scan (2018-2027) ($MN)
Table 68 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) Scan (2018-2027) ($MN)
Table 69 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Positron Emission Tomography (PET) Scan (2018-2027) ($MN)
Table 70 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Computed Tomography (CT) Scan (2018-2027) ($MN)
Table 71 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Molecular Testing (2018-2027) ($MN)
Table 72 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Type (2018-2027) ($MN)
Table 73 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Follicular Carcinoma (2018-2027) ($MN)
Table 74 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Papillary Carcinoma (2018-2027) ($MN)
Table 75 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By End-user (2018-2027) ($MN)
Table 76 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Research & Academic Institutes (2018-2027) ($MN)
Table 77 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Hospitals & Ambulatory Surgery Centers (2018-2027) ($MN)
Table 78 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Cancer Diagnostic Centers (2018-2027) ($MN)
Table 79 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Independent Diagnostic Labs (2018-2027) ($MN)
Table 80 Asia-Pacific Thyroid Cancer Diagnostics Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)
Table 81 South America Thyroid Cancer Diagnostics Market Outlook, By Country (2018-2027) ($MN)
Table 82 South America Thyroid Cancer Diagnostics Market Outlook, By Technique (2018-2027) ($MN)
Table 83 South America Thyroid Cancer Diagnostics Market Outlook, By Imaging (2018-2027) ($MN)
Table 84 South America Thyroid Cancer Diagnostics Market Outlook, By Blood Tests (2018-2027) ($MN)
Table 85 South America Thyroid Cancer Diagnostics Market Outlook, By Biopsy (2018-2027) ($MN)
Table 86 South America Thyroid Cancer Diagnostics Market Outlook, By Ultrasound (2018-2027) ($MN)
Table 87 South America Thyroid Cancer Diagnostics Market Outlook, By Radioiodine Scan (2018-2027) ($MN)
Table 88 South America Thyroid Cancer Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) Scan (2018-2027) ($MN)
Table 89 South America Thyroid Cancer Diagnostics Market Outlook, By Positron Emission Tomography (PET) Scan (2018-2027) ($MN)
Table 90 South America Thyroid Cancer Diagnostics Market Outlook, By Computed Tomography (CT) Scan (2018-2027) ($MN)
Table 91 South America Thyroid Cancer Diagnostics Market Outlook, By Molecular Testing (2018-2027) ($MN)
Table 92 South America Thyroid Cancer Diagnostics Market Outlook, By Type (2018-2027) ($MN)
Table 93 South America Thyroid Cancer Diagnostics Market Outlook, By Follicular Carcinoma (2018-2027) ($MN)
Table 94 South America Thyroid Cancer Diagnostics Market Outlook, By Papillary Carcinoma (2018-2027) ($MN)
Table 95 South America Thyroid Cancer Diagnostics Market Outlook, By End-user (2018-2027) ($MN)
Table 96 South America Thyroid Cancer Diagnostics Market Outlook, By Research & Academic Institutes (2018-2027) ($MN)
Table 97 South America Thyroid Cancer Diagnostics Market Outlook, By Hospitals & Ambulatory Surgery Centers (2018-2027) ($MN)
Table 98 South America Thyroid Cancer Diagnostics Market Outlook, By Cancer Diagnostic Centers (2018-2027) ($MN)
Table 99 South America Thyroid Cancer Diagnostics Market Outlook, By Independent Diagnostic Labs (2018-2027) ($MN)
Table 100 South America Thyroid Cancer Diagnostics Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)
Table 101 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Country (2018-2027) ($MN)
Table 102 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Technique (2018-2027) ($MN)
Table 103 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Imaging (2018-2027) ($MN)
Table 104 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Blood Tests (2018-2027) ($MN)
Table 105 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Biopsy (2018-2027) ($MN)
Table 106 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Ultrasound (2018-2027) ($MN)
Table 107 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Radioiodine Scan (2018-2027) ($MN)
Table 108 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) Scan (2018-2027) ($MN)
Table 109 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Positron Emission Tomography (PET) Scan (2018-2027) ($MN)
Table 110 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Computed Tomography (CT) Scan (2018-2027) ($MN)
Table 111 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Molecular Testing (2018-2027) ($MN)
Table 112 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Type (2018-2027) ($MN)
Table 113 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Follicular Carcinoma (2018-2027) ($MN)
Table 114 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Papillary Carcinoma (2018-2027) ($MN)
Table 115 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By End-user (2018-2027) ($MN)
Table 116 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Research & Academic Institutes (2018-2027) ($MN)
Table 117 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Hospitals & Ambulatory Surgery Centers (2018-2027) ($MN)
Table 118 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Cancer Diagnostic Centers (2018-2027) ($MN)
Table 119 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Independent Diagnostic Labs (2018-2027) ($MN)
Table 120 Middle East & Africa Thyroid Cancer Diagnostics Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)
Note: Product cover images may vary from those shown
  • Bio-Rad Laboratories, Inc.
  • General Electric
  • Koninklijke Philips N.V.
  • Abbott
  • F.Hoffmann-La Roche Ltd.
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthcare GmbH
  • Toshiba Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll